July 31, 2010
Study Showed the Clinically Significant Therapeutic Benefit of Neupro® (rotigotine transdermal system) in the …
Study Showed the Clinically Significant Therapeutic Benefit of Neupro® (rotigotine transdermal system) in the ...
UCB today announced the results of a 6-month, randomized, double-blind, placebo-controlled clinical study, published in the journal Movement Disorders, showing that Neupro® provided sustained, clinically relevant improvements in symptoms of Restless Legs Syndrome .
Read more on PR Newswire via Yahoo! Finance
Filed under Pregnancy Tests by on Jul 31st, 2010. 
Leave a Comment